Skip to main content

Articles

Page 18 of 32

  1. While tumor suppressor p53 functions primarily as a transcription factor in the nucleus, cellular stress can cause p53 to translocate to the mitochondria and directly trigger a rapid apoptotic response. We hav...

    Authors: Phong Lu, Erica R. Vander Mause, Katherine E. Redd Bowman, Sarah M. Brown, Lisa Ahne and Carol S. Lim
    Citation: Journal of Ovarian Research 2019 12:45
  2. To detected both pregnancy and oncologic outcomes early stage low grade epithelial ovarian cancer (EOC) in one tertiary hospital of China.

    Authors: Jie Yin, Yongxue Wang, Ying Shan, Yan Li, Ying Jin and Lingya Pan
    Citation: Journal of Ovarian Research 2019 12:44
  3. Chemokines are involved in the homing of various cancer cells, including those of ovarian cancer (OvCa), to distant organs. They may also promote or inhibit cancer progression and metastasis. Hypoxia, a common...

    Authors: Santosh Kumar Singh, Manoj Kumar Mishra and Rajesh Singh
    Citation: Journal of Ovarian Research 2019 12:42
  4. Ovarian cancer is a common gynaecological cancer with a poor prognosis that poses a serious threat to human life and health. It is essential to explore the possible prognostic biomarkers of ovarian cancer. As ...

    Authors: Ziqian Sun, Liang Sun, Miao He, Ying Pang, Zhaoying Yang and Junrong Wang
    Citation: Journal of Ovarian Research 2019 12:41
  5. Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder characterized by obesity, hyperandrogenism, and insulin resistance (IR). MicroRNAs (miRNAs) are small noncoding RNA associated with ...

    Authors: Nearmeen M. Rashad, Marwa Abdel-Monem Ateya, Yasser S. Saraya, Walid Mohamed Elnagar, Khaled Fathy Helal, Mohamed El-Bakry Lashin, Amr Ahmed Abdelrhman, Ayman E. Alil and Mohammed S. Yousef
    Citation: Journal of Ovarian Research 2019 12:39
  6. Despite years of research, the treatment options and mortality rate for ovarian cancer remain relatively stagnant. Resistance to chemotherapy and high heterogeneity in mutations contribute to ovarian cancer’s ...

    Authors: Katherine Redd Bowman, Ji Hoon Kim and Carol S. Lim
    Citation: Journal of Ovarian Research 2019 12:38
  7. Epithelial ovarian cancer has the highest fatality rate of all gynecologic malignancies. Although the majority of patients achieve complete clinical response after initial cytoreductive surgery and platinum-ba...

    Authors: Samantha Cohen, Melissa Schwartz, Peter Dottino and Ann Marie Beddoe
    Citation: Journal of Ovarian Research 2019 12:36
  8. Ovarian cancer (OC) is the highest frequent malignant gynecologic tumor with very complicated pathogenesis. The purpose of the present academic work was to identify significant genes with poor outcome and thei...

    Authors: Hao Feng, Zhong-Yi Gu, Qin Li, Qiong-Hua Liu, Xiao-Yu Yang and Jun-Jie Zhang
    Citation: Journal of Ovarian Research 2019 12:35
  9. Ral interacting protein of 76 kDa (RLIP76) is multifunctional protein localized and distributed in the plasma membrane, cytosol, and nucleus of the cell. In tumorigenesis, RLIP76 emerges as a common feature fo...

    Authors: Dody Houston Billhaq and Seunghyung Lee
    Citation: Journal of Ovarian Research 2019 12:34
  10. Previous studies about the prognostic value of the HIPEC have yielded controversial results. Therefore, this study aims to assess the impact of HIPEC on patients with ovarian cancer.

    Authors: Guyu Zhang, Yimin Zhu, Chongdong Liu, Guangming Chao, Ran Cui and Zhenyu Zhang
    Citation: Journal of Ovarian Research 2019 12:33
  11. Ovarian carcinosarcoma, which contains sarcomatous and carcinomatous components, is a very rare tumor. The carcinomatous component is often adenocarcinoma, and squamous cell carcinoma is extremely rare. We her...

    Authors: Atsushi Daimon, Satoe Fujiwara, Yoshimichi Tanaka, Tomohito Tanaka and Masahide Ohmichi
    Citation: Journal of Ovarian Research 2019 12:32
  12. Hyperandrogenism is one of the cardinal symptoms in polycystic ovary syndrome and plays a key role in the pathogenesis of polycystic ovary syndrome. However, the precise effects and mechanisms of excess androg...

    Authors: Yuya Fujibe, Tsuyoshi Baba, Sachiko Nagao, Sayaka Adachi, Keiko Ikeda, Miyuki Morishita, Yoshika Kuno, Masahiro Suzuki, Masahito Mizuuchi, Hiroyuki Honnma, Toshiaki Endo and Tsuyoshi Saito
    Citation: Journal of Ovarian Research 2019 12:31
  13. Increased activity of the chaperones Hsp70 and Hsp90 is a common feature of solid tumours. Translocase of the outer mitochondrial membrane 34 (Tomm34) is a cochaperone of both Hsp70 and Hsp90 that was found to...

    Authors: Petr Muller, Philip J. Coates, Rudolf Nenutil, Filip Trcka, Roman Hrstka, Josef Chovanec, Veronika Brychtova and Borivoj Vojtesek
    Citation: Journal of Ovarian Research 2019 12:30
  14. Ovarian cancer is the 5th leading cause of death for women with cancer worldwide. In more than 70% of cases, it is only diagnosed at an advanced stage. Our study aims to give an update on the biological marker...

    Authors: Vincent Dochez, Hélène Caillon, Edouard Vaucel, Jérôme Dimet, Norbert Winer and Guillaume Ducarme
    Citation: Journal of Ovarian Research 2019 12:28
  15. To analyze the clinicopathological characteristics of subsequent pelvic masses after hysterectomy for benign diseases, and to compare the masses following hysterectomy with or without simultaneous bilateral sa...

    Authors: Xiaopei Chao, Xiaoxia Wang, Yu Xiao, Mingliang Ji, Shu Wang, Honghui Shi, Qingbo Fan, Lan Zhu, Jinhua Leng, Dawei Sun and Jinghe Lang
    Citation: Journal of Ovarian Research 2019 12:27
  16. Polycystic ovarian syndrome (PCOS) is a highly variable syndrome and one of the most common female endocrine disorders. Although the association inositols-glucomannan may represent a good therapeutic strategy ...

    Authors: Jacopo Troisi, Claudia Cinque, Luigi Giugliano, Steven Symes, Sean Richards, David Adair, Pierpaolo Cavallo, Laura Sarno, Giovanni Scala, Maria Caiazza and Maurizio Guida
    Citation: Journal of Ovarian Research 2019 12:25
  17. Ovarian cancer is the primary cause of cancer-associated deaths among gynaecological malignancies. Increasing evidence suggests that microRNAs may be potential biomarkers for the diagnosis and prognosis of can...

    Authors: Xinshuai Wang, Dejiu Kong, Chaokun Wang, Xuezhen Ding, Li Zhang, Mengqi Zhao, Jing Chen, Xiangyun Xu, Xiaochen Hu, Junqiang Yang and Shegan Gao
    Citation: Journal of Ovarian Research 2019 12:24
  18. Low-grade ovarian cancers represent up to 8% of all epithelial ovarian carcinomas (EOCs). Recent studies demonstrated that epithelial-mesenchymal transition (EMT) is crucial for the progression of EOCs. EMT pl...

    Authors: Paweł Sadłecki, Marek Grabiec, Dariusz Grzanka, Jakub Jóźwicki, Paulina Antosik and Małgorzata Walentowicz-Sadłecka
    Citation: Journal of Ovarian Research 2019 12:23
  19. Normal pubertal ovary displays all stages of follicular development and a biased BAX/BCL2 protein ratio in favor of pro-apoptotic BAX protein comparable to the adult ovary. However, adolescents suffering malig...

    Authors: María Itatí Albamonte, Mirta Susana Albamonte, Ricardo M. Bou-Khair, Luis Zuccardi and Alfredo Daniel Vitullo
    Citation: Journal of Ovarian Research 2019 12:22
  20. The cumulus expansion process is one of the LH mediated ovulatory processes. Hyaluronan synthase 2 (HAS2) regulates the synthesis of hyaluronic acid, the main component of the cumulus expansion process. Recent...

    Authors: Yuval Yung, Libby Ophir, Gil M. Yerushalmi, Micha Baum, Ariel Hourvitz and Ettie Maman
    Citation: Journal of Ovarian Research 2019 12:21
  21. Common cancerous histological types associated with endometriosis are clear cell carcinoma (CCC) and endometrioid carcinoma (EC). CCC is regarded as an aggressive, chemoresistant histological subtype. Magnetic...

    Authors: Sachiko Morioka, Ryuji Kawaguchi, Yuki Yamada, Kana Iwai, Chiharu Yoshimoto and Hiroshi Kobayashi
    Citation: Journal of Ovarian Research 2019 12:20
  22. Ovarian cancer (OC) is one of the most malignant gynecological tumors, associated with excess death rate (50–60%) in ovarian cancer patients. Particularly, among newly occurred ovarian cancer patients, 70% of ...

    Authors: Lei Zhang, Min Luo, Hongying Yang, Shaoyan Zhu, Xianliang Cheng and Chen Qing
    Citation: Journal of Ovarian Research 2019 12:19
  23. Virotherapy represents a promising approach for ovarian cancer. In this regard, conditionally replicative adenovirus (CRAd) has been translated to the context of human clinical trials. Advanced design of CRAds...

    Authors: Rebeca González-Pastor, Ahmad Mohammad Ashshi, Adel Galal El-Shemi, Igor P. Dmitriev, Elena A. Kashentseva, Zhi Hong Lu, S. Peter Goedegebuure, Osvaldo L. Podhajcer and David T. Curiel
    Citation: Journal of Ovarian Research 2019 12:18
  24. Relapsed epithelial ovarian cancer (EOC) is frequently treated with pegylated liposomal doxorubicin (PLD). Unfortunately, most patients do not benefit from treatment. Prediction of response is crucial to optim...

    Authors: Eleonora Ghisoni, Furio Maggiorotto, Fulvio Borella, Gloria Mittica, Sofia Genta, Gaia Giannone, Dionyssios Katsaros, Alberto Sciarrillo, Annamaria Ferrero, Ivana Sarotto, Jessica Erriquez, Maria Flavia Di Renzo, Massimo Aglietta and Giorgio Valabrega
    Citation: Journal of Ovarian Research 2019 12:17
  25. The aim of the present study was to investigate the prognostic significance of preoperative complete blood count inflammatory markers in women operated for invasive Epithelial Ovarian Cancer (EOC).

    Authors: Mehmet Ufuk Ceran, Umit Tasdemir, Eser Colak and Tayfun Güngör
    Citation: Journal of Ovarian Research 2019 12:16
  26. Ovarian cancer is the most lethal of all gynecologic malignancies. The relationship between sexual steroids receptors and ovarian cancer progression has been largely evaluated. The presence of progesterone rec...

    Authors: Enrique Pedernera, María J. Gómora, Flavia Morales-Vásquez, Delia Pérez-Montiel and Carmen Mendez
    Citation: Journal of Ovarian Research 2019 12:15
  27. In ovarian endometriomas (OE), the expression statuses of various steroid hormone receptors are altered compared with their expression statuses in eutopic endometrium (EE). For example, in OE, the expressions ...

    Authors: Ryo Maekawa, Yumiko Mihara, Shun Sato, Maki Okada, Isao Tamura, Masahiro Shinagawa, Yuichiro Shirafuta, Haruka Takagi, Toshiaki Taketani, Hiroshi Tamura and Norihiro Sugino
    Citation: Journal of Ovarian Research 2019 12:14
  28. Obesity is a chronic and multifactorial disease characterized by increased adipose tissue. In females, obesity leads to reduced ovulation and lower chances of conception in diseases like polycystic ovary syndr...

    Authors: R. O. A. Benevides, C. C. Vale, J. L. L. Fontelles, L. M. França, T. S. Teófilo, S. N. Silva, A. M. A. Paes and R. S. Gaspar
    Citation: Journal of Ovarian Research 2019 12:13
  29. The aim of this study was to (1) evaluate the ability of F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) parameters to predict suboptimal cytoreduction and (2) to create a...

    Authors: Gun Oh. Chong, Shin Young Jeong, Yoon Hee Lee, Hyun Jung Lee, Sang-Woo Lee, Hyung Soo Han, Dae Gy Hong and Yoon Soon Lee
    Citation: Journal of Ovarian Research 2019 12:12
  30. Epithelial ovarian cancer is the most lethal gynecologic malignancy. In most women, it is diagnosed at an advanced stage, which largely explains the poor prognosis of this malignancy. Germline mutations of the...

    Authors: Angiolo Gadducci, Valentina Guarneri, Fedro Alessandro Peccatori, Graziana Ronzino, Giuseppa Scandurra, Claudio Zamagni, Paolo Zola and Vanda Salutari
    Citation: Journal of Ovarian Research 2019 12:9
  31. Ovarian hyperstimulation syndrome remains a serious complication during in vitro fertilization cycles if high dose human chorionic gonadotropin (hCG) is used to trigger ovulation in high responder patients. Th...

    Authors: L. L. Engmann, B. S. Maslow, L. A. Kaye, D. W. Griffin, A. J. DiLuigi, D. W. Schmidt, D. R. Grow, J. C. Nulsen and C. A. Benadiva
    Citation: Journal of Ovarian Research 2019 12:8
  32. Ovarian clear cell carcinoma (OCCC) is the second most common ovarian cancer after serous carcinoma in Japan. OCCC has a more unfavorable clinical outcome due to a poor response to platinum-based chemotherapy,...

    Authors: Hiroyuki Suzuki, Mitsutake Yano, Mariko Miyazawa, Masaki Miyazawa, Naoki Ogane, Kosei Hasegawa, Hitoshi Tsuda, Masayuki Yoshida, Ryugo Okagaki, Osamu Ishihara and Masanori Yasuda
    Citation: Journal of Ovarian Research 2019 12:7
  33. Ovarian cancer (OC) is associated with high mortality in gynecological oncology; this is mainly due to the low diagnosis rate. Exosomal miRNA has demonstrated potential as a tumor biomarker. We aimed to explor...

    Authors: Ying Ying Su, Li Sun, Zhi Rui Guo, Jin Chang Li, Ting Ting Bai, Xiao Xiao Cai, Wen Han Li and Ye Fei Zhu
    Citation: Journal of Ovarian Research 2019 12:6
  34. The aim of this study was to determine the effect of vitamin D and probiotic co-administration on mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome (...

    Authors: Vahidreza Ostadmohammadi, Mehri Jamilian, Fereshteh Bahmani and Zatollah Asemi
    Citation: Journal of Ovarian Research 2019 12:5
  35. There has been increasing interest in the role of endocannabinoids as critical modulators of the female reproductive processes. Endocannabinoids are natural ligands of cannabinoid, vanilloid, and peroxisome pr...

    Authors: O’Llenecia S. Walker, Alison C. Holloway and Sandeep Raha
    Citation: Journal of Ovarian Research 2019 12:3
  36. Ovarian cancer remains the most fatal gynecologic malignancy worldwide due to delayed diagnosis as well as recurrence and drug resistance. Thus, the development of new tumor-related molecules with high sensiti...

    Authors: Kaipeng Xie, Chenyang Fu, Suli Wang, Hanzi Xu, Siyu Liu, Yang Shao, Zhen Gong, Xiaoli Wu, Bo Xu, Jing Han, Juan Xu, Pengfei Xu, Xuemei Jia and Jiangping Wu
    Citation: Journal of Ovarian Research 2019 12:1
  37. Sclerosing stromal tumors (SST) are rare, benign tumors classified as sex cord stromal tumors. To our knowledge, positron emission tomography with computed tomography (PET-CT) findings of SST have only been de...

    Authors: Hiroki Matsutani, Go Nakai, Takashi Yamada, Kazuhiro Yamamoto, Masahide Ohmichi and Yoshifumi Narumi
    Citation: Journal of Ovarian Research 2018 11:101
  38. Ovarian granulosa cell tumors (GCTs) are divided into adult GCT (AGCT) and juvenile GCT (JGCT). The AGCT is more common type, conversely, less than 5% of tumors are the JGCT and occur in mainly premenarchal gi...

    Authors: Yuki Inada, Go Nakai, Kazuhiro Yamamoto, Takashi Yamada, Yoshinobu Hirose, Yoshito Terai, Masahide Ohmichi and Yoshifumi Narumi
    Citation: Journal of Ovarian Research 2018 11:100
  39. Ficus deltoidea is one of the well-known medicinal plants in Malaysia that is traditionally used by the Malay community to treat various ailments and for maintenance of female reproductive health. The objective o...

    Authors: Siti Sarah Mohamad Zaid, Shatrah Othman and Normadiah M. Kassim
    Citation: Journal of Ovarian Research 2018 11:99

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.